サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1798138

血漿分画の世界市場、2025年～2029年

Global Plasma Fractionation Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 214 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
血漿分画の世界市場、2025年～2029年
出版日: 2025年08月12日
発行: TechNavio
ページ情報: 英文 214 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血漿分画市場は2024-2029年に156億8,510万米ドル、予測期間中のCAGRは7.3％で成長すると予測されます。

当レポートでは、血漿分画市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、呼吸器疾患やAATDで治療される血漿製品の普及、血漿由来製品のリストの増加、血漿ベースの製品を製造するM&Aの増加によって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 6.7%
CAGR 7.3%
増分額 156億8,510万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間における血漿分画市場の成長を促進する主な要因の一つとして、高齢者人口の増加と関連障害を挙げています。また、血漿製品の自給率向上のための政府戦略や血漿採取需要の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 血漿分画の世界市場 2019-2023
  • 製品別セグメント分析 2019-2023
  • 用途別セグメント分析 2019-2023
  • 技術別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響血漿分画の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：製品別

  • 市場セグメント
  • 比較：製品別
  • 免疫グロブリン：市場規模と予測 2024-2029
  • アルブミン：市場規模と予測 2024-2029
  • 凝固因子濃縮物：市場規模と予測 2024-2029
  • プロテアーゼ阻害剤：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：製品別

第9章 市場セグメンテーション：用途別

  • 市場セグメント
  • 比較：用途別
  • 免疫学：市場規模と予測 2024-2029
  • 神経学：市場規模と予測 2024-2029
  • 血液学：市場規模と予測 2024-2029
  • 集中治療：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：用途別

第10章 市場セグメンテーション：技術別

  • 市場セグメント
  • 比較：技術別
  • クロマトグラフィ：市場規模と予測 2024-2029
  • 濾過：市場規模と予測 2024-2029
  • 沈殿：市場規模と予測 2024-2029
  • 市場機会：技術別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024-2029
  • 欧州：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • カナダ：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • イタリア：市場規模と予測 2024-2029
  • インド：市場規模と予測 2024-2029
  • スペイン：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • ADMA Biologics Inc.
  • Bharat Serums and Vaccines Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • GC Biopharma Corp.
  • Grifols SA
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion SpA
  • LFB SA
  • Merck KGaA
  • Octapharma AG
  • Sanquin
  • SK Inc.
  • Takeda Pharmaceutical Co. Ltd.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Plasma Fractionation Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Product - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Product - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Product
  • Exhibits41: Data Table on Comparison by Product
  • Exhibits42: Chart on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Immunoglobulins - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Immunoglobulins - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Albumin - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Albumin - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Albumin - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Albumin - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Chart on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits55: Data Table on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits56: Chart on Protease inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits57: Data Table on Protease inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Market opportunity by Product ($ million)
  • Exhibits63: Data Table on Market opportunity by Product ($ million)
  • Exhibits64: Chart on Application - Market share 2024-2029 (%)
  • Exhibits65: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits66: Chart on Comparison by Application
  • Exhibits67: Data Table on Comparison by Application
  • Exhibits68: Chart on Immunology - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Immunology - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Immunology - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Neurology - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Chart on Hematology - Market size and forecast 2024-2029 ($ million)
  • Exhibits77: Data Table on Hematology - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Chart on Hematology - Year-over-year growth 2024-2029 (%)
  • Exhibits79: Data Table on Hematology - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Chart on Critical care - Market size and forecast 2024-2029 ($ million)
  • Exhibits81: Data Table on Critical care - Market size and forecast 2024-2029 ($ million)
  • Exhibits82: Chart on Critical care - Year-over-year growth 2024-2029 (%)
  • Exhibits83: Data Table on Critical care - Year-over-year growth 2024-2029 (%)
  • Exhibits84: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits85: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits86: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits87: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits88: Market opportunity by Application ($ million)
  • Exhibits89: Data Table on Market opportunity by Application ($ million)
  • Exhibits90: Chart on Technology - Market share 2024-2029 (%)
  • Exhibits91: Data Table on Technology - Market share 2024-2029 (%)
  • Exhibits92: Chart on Comparison by Technology
  • Exhibits93: Data Table on Comparison by Technology
  • Exhibits94: Chart on Chromatography - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Chromatography - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Chromatography - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Chromatography - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Chart on Filtration - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Data Table on Filtration - Market size and forecast 2024-2029 ($ million)
  • Exhibits100: Chart on Filtration - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Data Table on Filtration - Year-over-year growth 2024-2029 (%)
  • Exhibits102: Chart on Precipitation - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Data Table on Precipitation - Market size and forecast 2024-2029 ($ million)
  • Exhibits104: Chart on Precipitation - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Data Table on Precipitation - Year-over-year growth 2024-2029 (%)
  • Exhibits106: Market opportunity by Technology ($ million)
  • Exhibits107: Data Table on Market opportunity by Technology ($ million)
  • Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits109: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits110: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits111: Chart on Geographic comparison
  • Exhibits112: Data Table on Geographic comparison
  • Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits166: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits167: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits168: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits169: Market opportunity By Geographical Landscape ($ million)
  • Exhibits170: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits171: Impact of drivers and challenges in 2024 and 2029
  • Exhibits172: Overview on criticality of inputs and factors of differentiation
  • Exhibits173: Overview on factors of disruption
  • Exhibits174: Impact of key risks on business
  • Exhibits175: Companies covered
  • Exhibits176: Company ranking index
  • Exhibits177: Matrix on companies position and classification
  • Exhibits178: ADMA Biologics Inc. - Overview
  • Exhibits179: ADMA Biologics Inc. - Business segments
  • Exhibits180: ADMA Biologics Inc. - Key news
  • Exhibits181: ADMA Biologics Inc. - Key offerings
  • Exhibits182: ADMA Biologics Inc. - Segment focus
  • Exhibits183: SWOT
  • Exhibits184: Bharat Serums and Vaccines Ltd. - Overview
  • Exhibits185: Bharat Serums and Vaccines Ltd. - Product / Service
  • Exhibits186: Bharat Serums and Vaccines Ltd. - Key offerings
  • Exhibits187: SWOT
  • Exhibits188: CSL Ltd. - Overview
  • Exhibits189: CSL Ltd. - Business segments
  • Exhibits190: CSL Ltd. - Key news
  • Exhibits191: CSL Ltd. - Key offerings
  • Exhibits192: CSL Ltd. - Segment focus
  • Exhibits193: SWOT
  • Exhibits194: Emergent BioSolutions Inc. - Overview
  • Exhibits195: Emergent BioSolutions Inc. - Product / Service
  • Exhibits196: Emergent BioSolutions Inc. - Key offerings
  • Exhibits197: SWOT
  • Exhibits198: GC Biopharma Corp. - Overview
  • Exhibits199: GC Biopharma Corp. - Product / Service
  • Exhibits200: GC Biopharma Corp. - Key offerings
  • Exhibits201: SWOT
  • Exhibits202: Grifols SA - Overview
  • Exhibits203: Grifols SA - Business segments
  • Exhibits204: Grifols SA - Key news
  • Exhibits205: Grifols SA - Key offerings
  • Exhibits206: Grifols SA - Segment focus
  • Exhibits207: SWOT
  • Exhibits208: Intas Pharmaceuticals Ltd. - Overview
  • Exhibits209: Intas Pharmaceuticals Ltd. - Product / Service
  • Exhibits210: Intas Pharmaceuticals Ltd. - Key offerings
  • Exhibits211: SWOT
  • Exhibits212: Kamada Ltd. - Overview
  • Exhibits213: Kamada Ltd. - Business segments
  • Exhibits214: Kamada Ltd. - Key offerings
  • Exhibits215: Kamada Ltd. - Segment focus
  • Exhibits216: SWOT
  • Exhibits217: Kedrion SpA - Overview
  • Exhibits218: Kedrion SpA - Product / Service
  • Exhibits219: Kedrion SpA - Key offerings
  • Exhibits220: SWOT
  • Exhibits221: LFB SA - Overview
  • Exhibits222: LFB SA - Product / Service
  • Exhibits223: LFB SA - Key offerings
  • Exhibits224: SWOT
  • Exhibits225: Merck KGaA - Overview
  • Exhibits226: Merck KGaA - Business segments
  • Exhibits227: Merck KGaA - Key news
  • Exhibits228: Merck KGaA - Key offerings
  • Exhibits229: Merck KGaA - Segment focus
  • Exhibits230: SWOT
  • Exhibits231: Octapharma AG - Overview
  • Exhibits232: Octapharma AG - Product / Service
  • Exhibits233: Octapharma AG - Key offerings
  • Exhibits234: SWOT
  • Exhibits235: Sanquin - Overview
  • Exhibits236: Sanquin - Product / Service
  • Exhibits237: Sanquin - Key offerings
  • Exhibits238: SWOT
  • Exhibits239: SK Inc. - Overview
  • Exhibits240: SK Inc. - Product / Service
  • Exhibits241: SK Inc. - Key offerings
  • Exhibits242: SWOT
  • Exhibits243: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits244: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits245: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits246: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits247: SWOT
  • Exhibits248: Inclusions checklist
  • Exhibits249: Exclusions checklist
  • Exhibits250: Currency conversion rates for US$
  • Exhibits251: Research methodology
  • Exhibits252: Information sources
  • Exhibits253: Data validation
  • Exhibits254: Validation techniques employed for market sizing
  • Exhibits255: Data synthesis
  • Exhibits256: 360 degree market analysis
  • Exhibits257: List of abbreviations
目次
Product Code: IRTNTR77166

The plasma fractionation market is forecasted to grow by USD 15,685.1 mn during 2024-2029, accelerating at a CAGR of 7.3% during the forecast period. The report on the plasma fractionation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of plasma products treated in respiratory diseases and aatd, growing list of plasma-derived products, and increasing in mergers and acquisitions producing plasma-based products.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.7%
CAGR7.3%
Incremental Value$15,685.1 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's plasma fractionation market is segmented as below:

By Product

    • Immunoglobulins
    • Albumin
    • Coagulation factor concentrates
    • Protease inhibitors
    • Others

By Application

    • Immunology
    • Neurology
    • Hematology
    • Critical care
    • Others

By Technology

    • Chromatography
    • Filtration
    • Precipitation

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing elderly population and related disorders as one of the prime reasons driving the plasma fractionation market growth during the next few years. Also, government strategies for increasing self-sufficiency for plasma products and rising demand for plasma collection will lead to sizable demand in the market.

The report on the plasma fractionation market covers the following areas:

    • Plasma Fractionation Market sizing
    • Plasma Fractionation Market forecast
    • Plasma Fractionation Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma fractionation market vendors that include ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma Corp., Grifols SA, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion SpA, LFB SA, Merck KGaA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd.. Also, the plasma fractionation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Plasma Fractionation Market 2019 - 2023
    • Historic Market Size - Data Table on Global Plasma Fractionation Market 2019 - 2023 ($ million)
  • 5.2 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.3 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.4 Technology segment analysis 2019 - 2023
    • Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in the global plasma fractionation market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

  • 8.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 8.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 8.3 Immunoglobulins - Market size and forecast 2024-2029
    • Chart on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunoglobulins - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunoglobulins - Year-over-year growth 2024-2029 (%)
  • 8.4 Albumin - Market size and forecast 2024-2029
    • Chart on Albumin - Market size and forecast 2024-2029 ($ million)
    • Data Table on Albumin - Market size and forecast 2024-2029 ($ million)
    • Chart on Albumin - Year-over-year growth 2024-2029 (%)
    • Data Table on Albumin - Year-over-year growth 2024-2029 (%)
  • 8.5 Coagulation factor concentrates - Market size and forecast 2024-2029
    • Chart on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
    • Data Table on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
    • Chart on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
    • Data Table on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
  • 8.6 Protease inhibitors - Market size and forecast 2024-2029
    • Chart on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
    • Data Table on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
    • Chart on Protease inhibitors - Year-over-year growth 2024-2029 (%)
    • Data Table on Protease inhibitors - Year-over-year growth 2024-2029 (%)
  • 8.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.8 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 9.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 9.3 Immunology - Market size and forecast 2024-2029
    • Chart on Immunology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunology - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunology - Year-over-year growth 2024-2029 (%)
  • 9.4 Neurology - Market size and forecast 2024-2029
    • Chart on Neurology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
    • Chart on Neurology - Year-over-year growth 2024-2029 (%)
    • Data Table on Neurology - Year-over-year growth 2024-2029 (%)
  • 9.5 Hematology - Market size and forecast 2024-2029
    • Chart on Hematology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hematology - Market size and forecast 2024-2029 ($ million)
    • Chart on Hematology - Year-over-year growth 2024-2029 (%)
    • Data Table on Hematology - Year-over-year growth 2024-2029 (%)
  • 9.6 Critical care - Market size and forecast 2024-2029
    • Chart on Critical care - Market size and forecast 2024-2029 ($ million)
    • Data Table on Critical care - Market size and forecast 2024-2029 ($ million)
    • Chart on Critical care - Year-over-year growth 2024-2029 (%)
    • Data Table on Critical care - Year-over-year growth 2024-2029 (%)
  • 9.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by Technology

  • 10.1 Market segments
    • Chart on Technology - Market share 2024-2029 (%)
    • Data Table on Technology - Market share 2024-2029 (%)
  • 10.2 Comparison by Technology
    • Chart on Comparison by Technology
    • Data Table on Comparison by Technology
  • 10.3 Chromatography - Market size and forecast 2024-2029
    • Chart on Chromatography - Market size and forecast 2024-2029 ($ million)
    • Data Table on Chromatography - Market size and forecast 2024-2029 ($ million)
    • Chart on Chromatography - Year-over-year growth 2024-2029 (%)
    • Data Table on Chromatography - Year-over-year growth 2024-2029 (%)
  • 10.4 Filtration - Market size and forecast 2024-2029
    • Chart on Filtration - Market size and forecast 2024-2029 ($ million)
    • Data Table on Filtration - Market size and forecast 2024-2029 ($ million)
    • Chart on Filtration - Year-over-year growth 2024-2029 (%)
    • Data Table on Filtration - Year-over-year growth 2024-2029 (%)
  • 10.5 Precipitation - Market size and forecast 2024-2029
    • Chart on Precipitation - Market size and forecast 2024-2029 ($ million)
    • Data Table on Precipitation - Market size and forecast 2024-2029 ($ million)
    • Chart on Precipitation - Year-over-year growth 2024-2029 (%)
    • Data Table on Precipitation - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by Technology
    • Market opportunity by Technology ($ million)
    • Data Table on Market opportunity by Technology ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.10 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.11 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.12 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.14 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.15 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.16 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 ADMA Biologics Inc.
    • ADMA Biologics Inc. - Overview
    • ADMA Biologics Inc. - Business segments
    • ADMA Biologics Inc. - Key news
    • ADMA Biologics Inc. - Key offerings
    • ADMA Biologics Inc. - Segment focus
    • SWOT
  • 15.5 Bharat Serums and Vaccines Ltd.
    • Bharat Serums and Vaccines Ltd. - Overview
    • Bharat Serums and Vaccines Ltd. - Product / Service
    • Bharat Serums and Vaccines Ltd. - Key offerings
    • SWOT
  • 15.6 CSL Ltd.
    • CSL Ltd. - Overview
    • CSL Ltd. - Business segments
    • CSL Ltd. - Key news
    • CSL Ltd. - Key offerings
    • CSL Ltd. - Segment focus
    • SWOT
  • 15.7 Emergent BioSolutions Inc.
    • Emergent BioSolutions Inc. - Overview
    • Emergent BioSolutions Inc. - Product / Service
    • Emergent BioSolutions Inc. - Key offerings
    • SWOT
  • 15.8 GC Biopharma Corp.
    • GC Biopharma Corp. - Overview
    • GC Biopharma Corp. - Product / Service
    • GC Biopharma Corp. - Key offerings
    • SWOT
  • 15.9 Grifols SA
    • Grifols SA - Overview
    • Grifols SA - Business segments
    • Grifols SA - Key news
    • Grifols SA - Key offerings
    • Grifols SA - Segment focus
    • SWOT
  • 15.10 Intas Pharmaceuticals Ltd.
    • Intas Pharmaceuticals Ltd. - Overview
    • Intas Pharmaceuticals Ltd. - Product / Service
    • Intas Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 15.11 Kamada Ltd.
    • Kamada Ltd. - Overview
    • Kamada Ltd. - Business segments
    • Kamada Ltd. - Key offerings
    • Kamada Ltd. - Segment focus
    • SWOT
  • 15.12 Kedrion SpA
    • Kedrion SpA - Overview
    • Kedrion SpA - Product / Service
    • Kedrion SpA - Key offerings
    • SWOT
  • 15.13 LFB SA
    • LFB SA - Overview
    • LFB SA - Product / Service
    • LFB SA - Key offerings
    • SWOT
  • 15.14 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.15 Octapharma AG
    • Octapharma AG - Overview
    • Octapharma AG - Product / Service
    • Octapharma AG - Key offerings
    • SWOT
  • 15.16 Sanquin
    • Sanquin - Overview
    • Sanquin - Product / Service
    • Sanquin - Key offerings
    • SWOT
  • 15.17 SK Inc.
    • SK Inc. - Overview
    • SK Inc. - Product / Service
    • SK Inc. - Key offerings
    • SWOT
  • 15.18 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations